Frequent Psychiatric Hospitalization Is Highest Among Those With Schizophrenia

The odds of becoming a “high utilizer” of psychiatric hospital services are highest among those with schizophrenia, at 111% higher. …

You must be logged-in to view this content.

Join Log In

The STARR Coalition Seeks To Destigmatize Mental Health Research Through Innovative Initiatives & Programs

Join Luke Kramer, Executive Director of the Starr Coalition, as he discusses stigma involved in mental health research, goals for …

You must be logged-in to view this content.

Join Log In

Digital Technologies For Schizophrenia

Dr. Brian Kirkpatrick, MD, MSPH, Chair of Psychiatry and Behavioral Sciences at the University of Nevada, Reno School of Medicine, …

You must be logged-in to view this content.

Join Log In

Telemedicine & Medication Adherence

Nonadherence to psychotropic medication is one of the major obstacles when treating mental illnesses. Approximately 60% of individuals diagnosed with …

You must be logged-in to view this content.

Join Log In

Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

You must be logged-in to view this content.

Join Log In

PANSS-6: A Tool For Measure-Based Care In Schizophrenia

You must be logged-in to view this content.

Join Log In

Effects Of Brain-Derived Neurotrophic Factor & C-Reactive Protein On Cognitive Impairment In Schizophrenia: Existing Evidence

You must be logged-in to view this content.

Join Log In

Mental Health Education Roundtable: A Collaborative Discussion Among A Parent, Advocate & Educator: Follow-Up Q&A

During this question-and-answer session, Jessica Hull, MS, Amy Molloy, MSW, and Michael Townsend, MA, LMSW, respond to unanswered questions from …

You must be logged-in to view this content.

Join Log In

CooperRiis Launches New Intensive Clinical Program For Mental Health & Addiction Treatment

You must be logged-in to view this content.

Join Log In

Household Size & Employment Status Are Key Factors In Mental Health Among Canadians During COVID-19

You must be logged-in to view this content.

Join Log In

“I’m Here…”: Helping Those With Mood Disorders

You must be logged-in to view this content.

Join Log In

Suicide Rate For People With Schizophrenia Disorder Is 1.7% During 10 Years Post-Diagnosis

About 1.7% of people first diagnosed with a schizophrenia spectrum disorder (SSD) died by suicide. During the 10 years post-diagnosis, …

You must be logged-in to view this content.

Join Log In

Navigating Telepsychiatry In Mental Health Care: A Discussion With A Peer Specialist & A Caregiver

On average, in the United States there is one mental health provider for every 536 individuals, and providers are not …

You must be logged-in to view this content.

Join Log In

The EARLY Clinic Program: Treating First-Episode Psychosis

You must be logged-in to view this content.

Join Log In

Population Density & Genetic Risk For Schizophrenia

You must be logged-in to view this content.

Join Log In

Examining The Relationship Between Psychotic Experiences & Suicidal Behaviors

Introduction
Over the last 20 years, researchers have extensively delved into psychotic experiences in the general population. While these hallucinatory experiences …

You must be logged-in to view this content.

Join Log In

Follow-Up Mental Health Visits Lower Among Those With Substance Addiction

Follow-up mental health visits, within 14 days after emergency department contact, are lower among those with substance addiction than those …

You must be logged-in to view this content.

Join Log In

Mental Health Education: A Discussion With A Psychiatrist

This podcast features Madhukar Trivedi, MD, and Kim Lonergan, RN, MSN, discussing mental health education around the globe. Their conversation …

You must be logged-in to view this content.

Join Log In

Addcounsel Launches Orchestrate Health, At-Home Mental Health Care Service In UK

You must be logged-in to view this content.

Join Log In

Interacting With First Responders Webinar: Follow-Up Q&A Podcast

Elizabeth DiNapoli sits down with Kathy Day to respond to unanswered questions from PsychU’s Interacting with First Responders webinar. Their …

You must be logged-in to view this content.

Join Log In

2020 MHA Minority Mental Health: Facts & Stats

You must be logged-in to view this content.

Join Log In

2020 BIPOC Mental Health Month Toolkit

You must be logged-in to view this content.

Join Log In

U.N. Warns Of Global Mental Health Crisis Due To COVID-19 Pandemic

On May 13, 2020, the United Nations (UN) issued a warning that the coronavirus disease 2019 (COVID-19) pandemic could create …

You must be logged-in to view this content.

Join Log In

Role Of Pharmacogenetics Testing In Psychiatry

Joseph Goldberg, MD, and Lisa Goldstone, PharmD, MS, discuss the benefits and limitations of pharmacogenetics testing on current psychiatric practice …

You must be logged-in to view this content.

Join Log In

Could NMR-Spectroscopy Eventually Supplement Differential Diagnosis Decisions?

You must be logged-in to view this content.

Join Log In

Association of Cognition With Level Of Negative Symptomatology In First-Episode Psychosis

Schizophrenia is marked by considerable heterogeneity in clinical course and functional outcome. Two underlying reasons for this are differences in …

You must be logged-in to view this content.

Join Log In

CMS Continues Efforts To Expand Access To Telehealth Services

You must be logged-in to view this content.

Join Log In

Up To Half Of Americans Say Pandemic Has A ‘Serious Impact’ On Their Mental Health

You must be logged-in to view this content.

Join Log In

9% Of Long-Term Care Residents Receive Less Medication Than Needed Due To Inadequate Prescription Coverage

You must be logged-in to view this content.

Join Log In

About 10% Of Medicaid Beneficiaries With Behavioral Health Disorders Made Telehealth Visits In 2017

You must be logged-in to view this content.

Join Log In

Behavioral Health Provider Organizations Can Accept Donations Of Devices & Data Plans To Facilitate Telehealth During The COVID-19 Outbreak

You must be logged-in to view this content.

Join Log In

A Caregiver’s Perspective On Mental Health During Coronavirus Pandemic

As a caregiver, Kathy Day explains how her family member with schizophrenia is adjusting to life during the coronavirus pandemic. …

You must be logged-in to view this content.

Join Log In

Digital Endpoints & Medication Optimization

In this presentation Dr. Timothy Aungst, Associate Professor of Pharmacy at the Massachusetts College of Pharmacy and Health Sciences, discusses …

You must be logged-in to view this content.

Join Log In

The Nurse’s Role In Integrating & Improving Behavioral Care

You must be logged-in to view this content.

Join Log In

The Importance Of First Episode Psychosis Programs

You must be logged-in to view this content.

Join Log In

14% Of U.S. Households Have Accessed Mental Health Care To Address Problems Related To COVID-19 Pandemic

About 14% of households in the United States have had an immediate family member access mental health care to address …

You must be logged-in to view this content.

Join Log In

The Pharmacist’s Perspective During The Pandemic

In this presentation, Dr. Timothy Aungst, Associate Professor of Pharmacy Practice at the Massachusetts College of Pharmacy and Health Sciences, …

You must be logged-in to view this content.

Join Log In

National Quality Forum Endorses Four Behavioral Health Measures

You must be logged-in to view this content.

Join Log In

Two Distinct Subtypes Of Schizophrenia Discovered

You must be logged-in to view this content.

Join Log In

Are Interventions For Reducing Stigma Toward People With Severe Mental Illness Effective?

You must be logged-in to view this content.

Join Log In

Perspectives From The COVID-19 US Epicenter With Dr. René Kahn, Schizophrenia Section Advisor

You must be logged-in to view this content.

Join Log In

Impact Of Second-Generation Antipsychotics

Dr. Rajiv Tandon outlines treatment options for individuals with schizophrenia and the impact the illness can have on their daily functioning. …

You must be logged-in to view this content.

Join Log In

COVID-19 & Your Mental Health

Download Resource

Provided with permission from Mental Health America, a PsychU Supporting Organization. To learn more about MHA, please visit their …

You must be logged-in to view this content.

Join Log In

Does Targeting Stigma Improve Quality Of Life For Individuals With Schizophrenia Or Major Depression?

You must be logged-in to view this content.

Join Log In

The Impact Of 2nd Generation Antipsychotic Side Effects On Functioning From Schizophrenia Patient Perspective: A Global Patient Centered Study

You must be logged-in to view this content.

Join Log In

Mental Health Education Roundtable: A Collaborative Discussion Among A Parent, Advocate & Educator

In July 2018, the state of New York became the first to require mental health instruction for all students, grades …

You must be logged-in to view this content.

Join Log In

Overcoming Stigma In Mental Health

You must be logged-in to view this content.

Join Log In

Fighting Loneliness In Social Distancing: A Conversation With Dr. Gaurava Agarwal

Dr. Gaurava Agarwal discusses the effect of social distancing, including loneliness, which he breaks down into three categories. He also …

You must be logged-in to view this content.

Join Log In

Joint Commission Releases New Enhanced Addiction Standards For Behavioral Health

You must be logged-in to view this content.

Join Log In

Use Of Telemedicine & Technology In The Treatment Of Mental Health During The COVID-19 Crisis

The COVID-19 crisis has increased the use of telemedicine to adapt to new social distancing guidelines. Transitioning to digital health …

You must be logged-in to view this content.

Join Log In

Balancing Act: Preventing Burnout For Health Care Professionals During The Coronavirus Pandemic & Times Of Crisis

You must be logged-in to view this content.

Join Log In

Meeting The Treatment Team Transitioning From Primary Care To Psychiatry

When primary care providers recommend mental health treatment, patients can feel apprehensive and flustered. Health care providers are asked questions …

You must be logged-in to view this content.

Join Log In

Nurses’ Role In Behavioral Health During The Crisis Of COVID-19

Anxiety, fear, and trauma can be rampant during times of natural disaster. Kimberly Lonergan, RN, MSN, interviews Tony Amberg to …

You must be logged-in to view this content.

Join Log In

Perspectives Of A Caregiver: Suicide & Safety Questions

This podcast highlights Kathy Day’s experience as a caregiver to her relative with mental illness. Ms. Day answers questions relating …

You must be logged-in to view this content.

Join Log In

Reentry Interventions Are More Successful When They Address Dynamic Risk Factors

Community reentry following incarceration is more likely to be successful if the reentry interventions address dynamic factors that affect the …

You must be logged-in to view this content.

Join Log In

Stigma’s Impact In Prison & After Release On Individuals With Mental Illness

You must be logged-in to view this content.

Join Log In

Cannabis: Potential Risks & Benefits In Mental Health

How might the use of marijuana or its components affect behavioral or physical health? During this webinar, Joseph McEvoy, MD, …

You must be logged-in to view this content.

Join Log In

The Impact Of COVID-19 On Mental Health Care: Perspectives From A Peer Specialist

Today’s podcast will focus on COVID-19’s impact on the work of a peer specialist in mental health care. It will …

You must be logged-in to view this content.

Join Log In

The COVID-19 Pandemic Effect On Advocacy: Perspective From Mental Health America

Mr. Paul Gionfriddo, President and CEO of Mental Health America (MHA), and Dr. Dennis Pabis, Senior Medical Science Liaison with …

You must be logged-in to view this content.

Join Log In

Disclosing To Others Fact Sheet

You must be logged-in to view this content.

Join Log In

Oregon Launches Family Connects Program To Improve Infant & Maternal Health

On February 13, 2020, the Oregon Health Authority (OHA) launched Family Connects to offer universal home visiting services to all …

You must be logged-in to view this content.

Join Log In

Sarpy County, Nebraska Planning New Jail With Space For Mental Health Resources

You must be logged-in to view this content.

Join Log In

Colorado Proposes Bill To Reimburse Behavioral Health Peer Support Professionals

You must be logged-in to view this content.

Join Log In

Impact Of Novel Coronavirus Pandemic On Mental Health

The COVID-19 pandemic isn’t affecting physical health only; it has an impact on mental health as well. In this webinar, Paul …

You must be logged-in to view this content.

Join Log In

Psychoneuroimmunology: Mood Disorders Part 2 In PNI Series

Drs. Rachel Self, Carolyn Tyler, and Heather Davidson provide an understanding of the immune system and neuroinflammation and their impact …

You must be logged-in to view this content.

Join Log In

Integrating Behavioral Care At A Nurse-Led Clinic

You must be logged-in to view this content.

Join Log In

Predicting Psychiatric Readmissions For Individuals Living With Borderline Personality Disorder

Borderline personality disorder (BPD) affects roughly 1% of the general population. Individuals living with this condition experience common symptomology with …

You must be logged-in to view this content.

Join Log In

App-Supported Smartphone Interventions for Mental Health Problems

You must be logged-in to view this content.

Join Log In

Northwestern University Recovery From Early Episode Psychosis Program (REPP)

Morris Goldman, MD, Stacy Prokopios, LCSW, and Lauren Walker, OTR/L, provide an overview of the Recovery from Early Episode Psychosis …

You must be logged-in to view this content.

Join Log In

Utilizing PsychU As A Resident

You must be logged-in to view this content.

Join Log In

Research Links Psychotic Disorders With Increased Age-Related Cognitive Impairment

You must be logged-in to view this content.

Join Log In

A Prescription For Pharmacist Intervention

Despite the well-known prevalence of mental health conditions, they are woefully undertreated. Consider this: About one in five Americans has …

You must be logged-in to view this content.

Join Log In

Psychotic Experiences & Psychiatric Comorbidity In The General Population Of Southeast London

You must be logged-in to view this content.

Join Log In

Factors Influencing Who Benefits From Cognitive Remediation Therapy

You must be logged-in to view this content.

Join Log In

Interacting With First Responders

You must be logged-in to view this content.

Join Log In

Interacting With First Responders

Approximately 15% of men and 30% of women jailed have a serious mental illness (SMI).1 Educated first responders can potentially …

You must be logged-in to view this content.

Join Log In

Painting A Broader Picture: Cognitive Remediation As A Nonpharmacologic Option For Treating Secondary Symptom Targets In Schizophrenia

You must be logged-in to view this content.

Join Log In

Types Of Mental Health Professionals Fact Sheet

You must be logged-in to view this content.

Join Log In

Depression Accounted For 44% Of 2018 Pennsylvania Mental Disorder Hospital Stays

In 2018, depression accounted for 44% of hospital stays for mental health issues in Pennsylvania. This was followed by schizophrenia …

You must be logged-in to view this content.

Join Log In

Social Cognition Treatment In Schizophrenia: Status & Opportunities

Individuals with schizophrenia struggle to interact with others due to impaired social cognition. Four capabilities in particular are compromised: 1.) …

You must be logged-in to view this content.

Join Log In

Cognitive Remediation: What Is the Impact of Peer Interaction?

You must be logged-in to view this content.

Join Log In

Medicaid Beneficiaries With Schizophrenia Had 50% To 92% Higher Health Care Utilization Rates

You must be logged-in to view this content.

Join Log In

Nearly One-Third Of Veterans With Schizophrenia Received No Antipsychotic Medication During The 12 Months Following Diagnosis

You must be logged-in to view this content.

Join Log In

Recovery After Initial Schizophrenic Episode – Early Treatment Program (RAISE-ETP) Interview With Dr. John Kane

John M. Kane provides commentary on the results of the Recovery After Initial Schizophrenic Episode – Early Treatment Program (RAISE-ETP) …

You must be logged-in to view this content.

Join Log In

Surviving Suicide: Interview with Laura Kaponer, Peer Support Specialist

You must be logged-in to view this content.

Join Log In

Meet The Treatment Team: Physician Assistant

You must be logged-in to view this content.

Join Log In

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

You must be logged-in to view this content.

Join Log In

PsychU Supporters: Cummings Institute – Doctor Of Behavioral Health Program

You must be logged-in to view this content.

Join Log In

Introduction To Marijuana

You must be logged-in to view this content.

Join Log In

Follow Up Q&A With Dr. Rowland – The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Join Log In

PsychU Supporters: An Interview With Trinitas Regional Medical Center (TRMC)

We invite you to listen to our interview with James McCreath, Ph.D., LCSW, VP of Behavioral Health and Psychiatry at …

You must be logged-in to view this content.

Join Log In

PsychU Supporters: An Interview With Mental Health America (MHA)

Paul Gionfriddo, President and CEO of Mental Health America (MHA), sits down with PsychU to discuss the history and purpose …

You must be logged-in to view this content.

Join Log In

Follow Up Q&A With Dr. Murrough – The Role Of Glutamate In Mood Disorders & Schizophrenia

During this question and answer session, Dr. James Murrough responds to unanswered questions from the PsychU webinar, “The Role of …

You must be logged-in to view this content.

Join Log In

Long-Acting Injectable Antipsychotics & How To Give An Intramuscular Injection

You must be logged-in to view this content.

Join Log In

Cognitive Function & Neuroprotection In Schizophrenia

Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as …

You must be logged-in to view this content.

Join Log In

Recovery After Initial Schizophrenic Episode – Early Treatment Program (RAISE-ETP)

You must be logged-in to view this content.

Join Log In

The Neurobiology Of Endocannabinoids

You must be logged-in to view this content.

Join Log In

The Neurobiology Of Opioids

You must be logged-in to view this content.

Join Log In

The Interplay Between Sleep & Physical Activity For Patients Living With Schizophrenia

You must be logged-in to view this content.

Join Log In

Half Of People With Early Psychosis Symptoms May Not Have Schizophrenia

You must be logged-in to view this content.

Join Log In

Is It Suicide Risk Or Risk Of Psychiatric Illness? Re-Examining The Nature Of Sex-Specific Suicide Risk Factors

You must be logged-in to view this content.

Join Log In

State Of The Science 2019: Advances In Understanding & Treating Schizophrenia

You must be logged-in to view this content.

Join Log In

The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Join Log In

Webinar Summary – The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Join Log In

California’s Ventura County Seeks Services For Early Detection, Intervention & Prevention Of Psychosis

You must be logged-in to view this content.

Join Log In

RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia

You must be logged-in to view this content.

Join Log In

Relapse Risk Assessment In Patients With Schizophrenia (RASP)

You must be logged-in to view this content.

Join Log In

Long-Acting Injectable Antipsychotic Screening, Utilization, & Effects: The RUHS Medical Center Case Study

Riverside University Health System (RUHS) is an academic, tertiary care medical center and county safety-net facility operating a 77 bed …

You must be logged-in to view this content.

Join Log In

Understanding Psychiatric Diagnoses Using Mnemonics: Schizophrenia

You must be logged-in to view this content.

Join Log In

Webinar Summary: Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Join Log In

Hospital Utilization Following Antipsychotic Medication Dose Reduction: Balancing Side Effect Management With Risk Of Relapse

You must be logged-in to view this content.

Join Log In

FDA Authorizes 23andMe Direct-To-Consumer Pharmacogenetic Reports

You must be logged-in to view this content.

Join Log In

Webinar Summary – Beyond Molecular Biomarkers In Psychiatry: Advances In The Digital Age

You must be logged-in to view this content.

Join Log In

Pharmacological Treatment Factors Associated With Type 2 Diabetes In Patients With Schizophrenia

You must be logged-in to view this content.

Join Log In

Webinar Summary – Humanizing Bipolar Disorder: David’s Story Of Hope, Recovery, & Wellness

You must be logged-in to view this content.

Join Log In

Polypharmacy Therapy For Schizophrenia Increases Risk For Type 2 Diabetes

You must be logged-in to view this content.

Join Log In

The Prevalence Of Antipsychotic Polypharmacy Decreased 4.6% Between 2008 & 2014

You must be logged-in to view this content.

Join Log In

Machine Learning Helps Predict Instance & Treatment Outcomes Of Schizophrenia

You must be logged-in to view this content.

Join Log In

Webinar Summary – Can We Improve Functioning In Our Patients With Schizophrenia?: Side Effect Burden & Recovery Approach To Informed Decision Making

You must be logged-in to view this content.

Join Log In

Can We Improve Functioning In Our Patients With Schizophrenia?

Clinicians are tasked daily with making informed decisions regarding patients. During this webinar, Greg Mattingly, MD, Medical Director at St. …

You must be logged-in to view this content.

Join Log In

Webinar Summary – The Aftermath Of Suicide: What Can Be Done & How Should We Talk About It?

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, …

You must be logged-in to view this content.

Join Log In

Emergency Use 60% Higher Among Consumers With Schizophrenia & Not Taking Antipsychotics As Directed

North Carolina Medicaid beneficiaries diagnosed with schizophrenia who failed to take antipsychotic medications as directed had 60% more emergency department …

You must be logged-in to view this content.

Join Log In

Over 10% Of Ontario Suicide Deaths Are Among People With Schizophrenia

About 11.7% of the 5,650 people who died of suicide in Ontario, Canada from January 2008 through December 2012 had …

You must be logged-in to view this content.

Join Log In

Introducing RASP: Relapse Assessment In Schizophrenia Patients

Nearly 3.4 million adults, or 1.1% of the U.S. population, have a diagnosis of schizophrenia.1,2 As a chronic, relapsing3 condition, those who …

You must be logged-in to view this content.

Join Log In

Webinar Summary – Introducing RASP: Relapse Assessment In Schizophrenia Patients

You must be logged-in to view this content.

Join Log In

Early Intervention Services Have Superior Outcomes For Early-Phase Psychosis

People with early-phase psychosis who received a set of services considered “early intervention services” (EIS) had more symptom improvement, a …

You must be logged-in to view this content.

Join Log In

How Media & Movies Shape Our Perception Of Serious Mental Illness

During this webinar, experts Georgia Stevens, PhD, APRN, PMHCNS-BC, Psychiatric Nurse & Director of Partners in Aging & Long-Term Caregiving, …

You must be logged-in to view this content.

Join Log In

It’s A Small World: Similarities & Differences In Health Behaviors & Life Satisfaction Among Individuals With Mental Illness From Four Countries

You must be logged-in to view this content.

Join Log In

Where Are We Now? Recent Findings Push Research Beyond Initial Results From The CATIE Study

You must be logged-in to view this content.

Join Log In

Reducing Relapse In Schizophrenia Starts With Predicting Relapse

You must be logged-in to view this content.

Join Log In

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

You must be logged-in to view this content.

Join Log In

Five Years Of Specialised Early Intervention Versus Two Years Of Specialised Early Intervention Followed By Three Years Of Standard Treatment For Patients With A First Episode Psychosis: Randomised, Superiority, Parallel Group Trial In Denmark (OPUS II)

You must be logged-in to view this content.

Join Log In

The State Of Mental Health In America In 2018: An Interview With Paul Gionfriddo

Mental Health America (MHA), a leading nationwide nonprofit organization dedicated to promoting the mental wellness of all Americans, has released …

You must be logged-in to view this content.

Join Log In

Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use

In this interview, James McCreath, PhD, Vice President of Psychiatry & Behavioral Health at the Trinitas Regional Medical Center, discusses …

You must be logged-in to view this content.

Join Log In

Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE): Summary Results From Phase I

You must be logged-in to view this content.

Join Log In

Increasing Serum G72 Protein Levels In Patients With Schizophrenia: A Potential Candidate Biomarker

You must be logged-in to view this content.

Join Log In

Webinar Summary – Caring For The Patient With Schizophrenia: Nursing, Pharmacy, & Social Work Perspectives

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Join Log In

Caring For The Patient With Schizophrenia: Nursing, Pharmacy, & Social Work Perspectives

Given the complexity of schizophrenia and suboptimal treatment outcomes, it is important that a multidisciplinary approach be considered when caring …

You must be logged-in to view this content.

Join Log In

Stressors & Psychological Distress Among Informal Caregivers Of Relatives With Mental Illness

You must be logged-in to view this content.

Join Log In

23% Of Hospital Admissions For Psychosis Resulted In Readmission Within 30 Days

You must be logged-in to view this content.

Join Log In

Training Patients With Schizophrenia To Share Decisions With Their Psychiatrist: A Randomized-Controlled Trial

Key Messages

Many patients with schizophrenia would like to participate in shared decision-making (SDM) with their health care providers. In observed …

You must be logged-in to view this content.

Join Log In

Most States Fail To Provide Adequate Evidence-Based Treatment For Offenders With SMI

You must be logged-in to view this content.

Join Log In

Danish Consumers With Diabetes & Schizophrenia 10% Less Likely To Receive High-Quality Diabetes Care

You must be logged-in to view this content.

Join Log In

Webinar Summary – Tools To Assess & Address Medication Adherence In Patients With Serious Mental Illness

You must be logged-in to view this content.

Join Log In

Blood Test Detects Physiological Markers To Differentiate Depression From Schizophrenia

You must be logged-in to view this content.

Join Log In

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

You must be logged-in to view this content.

Join Log In

Webinar Summary – Early Intervention In Schizophrenia: Targeting Metabolic Dysfunction

You must be logged-in to view this content.

Join Log In

Early Intervention In Schizophrenia: Targeting Metabolic Dysfunction

Increasingly, schizophrenia is considered a medical psychiatric disease. There is evidence that metabolic changes occur within the first episode of …

You must be logged-in to view this content.

Join Log In

Webinar Summary – Pharmacogenomics & Personalized Medicine: Where Are We Now & Where Are We Going?

You must be logged-in to view this content.

Join Log In

20-Minute Screening Evaluates Cognitive Impairment Due To Schizophrenia

You must be logged-in to view this content.

Join Log In

Families & Medication Use & Adherence Among Latinos With Schizophrenia

You must be logged-in to view this content.

Join Log In

Reduced Insulin-Receptor Mediated Modulation Of Striatal Dopamine Release By Basal Insulin As A Possible Contributing Factor To Hyperdomaminergia In Schizophrenia

You must be logged-in to view this content.

Join Log In

Association Of Social Support & Quality Of Life Among People With Schizophrenia Receiving Community Psychiatric Service: A Cross-Sectional Study

You must be logged-in to view this content.

Join Log In

High-Intensity Transcranial Magnetic Stimulation Reduces Severity Of Auditory Hallucinations

You must be logged-in to view this content.

Join Log In

University Of Alberta & IBM Testing Artificial Intelligence To Diagnose Schizophrenia

You must be logged-in to view this content.

Join Log In

Why Schizophrenia Remains ‘Top Of Mind’ At Health Plans

You must be logged-in to view this content.

Join Log In

Data Show Criminal Justice Reform In California Has Not Benefited Prisoners With Mental Illness

You must be logged-in to view this content.

Join Log In

Self-Perceived Cognitive Deficits & Their Relationship With Internalized Stigma & Quality Of Life In Patients With Schizophrenia

You must be logged-in to view this content.

Join Log In

Ten-Year Outcomes Of First-Episode Psychoses In The MRC ÆSOP-10 Study

You must be logged-in to view this content.

Join Log In

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

You must be logged-in to view this content.

Join Log In

Coping Strategies & Self-Stigma In Patients With Schizophrenia-Spectrum Disorders

You must be logged-in to view this content.

Join Log In

Anxiety Symptoms In A Major Mood & Schizophrenia Spectrum Disorders

You must be logged-in to view this content.

Join Log In

Training To Enhance Psychiatrist Communication With Patients With Psychosis (TEMPO): Cluster Randomised Controlled Trial

You must be logged-in to view this content.

Join Log In

Long-Term Suicide Rate After Psychiatric Discharge Averages 484 Per 100,000 Person-Years

Long-term suicide rates after discharge from a psychiatric facility were estimated at a 10-year average of 484 suicides per 100,000 …

You must be logged-in to view this content.

Join Log In

Adherence To Antipsychotics Associated With Lower Psychiatric Hospitalization Rates & Expenditures

Adherence to antipsychotic therapy among Medicare Part D enrollees with schizophrenia is associated with a lower probability of psychiatric hospitalization …

You must be logged-in to view this content.

Join Log In

Study Shows Involving Individuals With Mental Illness In Managing Their Health May Prevent Emergency Room Visits

You must be logged-in to view this content.

Join Log In

Health Technology Intervention After Hospitalization For Schizophrenia: Service Utilization & User Satisfaction

You must be logged-in to view this content.

Join Log In

Clinical Application Of Psychopharmacology Of Schizophrenia – John Miller, MD

This interview with John Miller, MD is part 3 of the 3-part module series on Schizophrenia, from the Psychopharmacology Collection.

You must be logged-in to view this content.

Join Log In

Mental Health America’s National Peer Support Specialist Certification

You must be logged-in to view this content.

Join Log In

Recovery In Schizophrenia: What Consumers Know & Do Not Know

You must be logged-in to view this content.

Join Log In

No Supportive Evidence For The Use Of Multiple Long-Acting Antipsychotic Therapies In Patients With Schizophrenia

You must be logged-in to view this content.

Join Log In

A Tool To Predict Risk Of Violence In Individuals With Schizophrenia Spectrum Or Bipolar Disorder

You must be logged-in to view this content.

Join Log In

Cerebral White Matter Structure Is Associated With DSM-5 Schizophrenia Symptom Dimensions

You must be logged-in to view this content.

Join Log In

Neuroinflammation & White Matter Pathology In Schizophrenia: Systematic Review

You must be logged-in to view this content.

Join Log In

Neuroinflammation & Psychiatric Illness

You must be logged-in to view this content.

Join Log In

Genetics Of Schizophrenia & Smoking: An Approach To Studying Their Comorbidity Based On Epidemiological Findings

You must be logged-in to view this content.

Join Log In

Genetic Correlates Of Medical Comorbidity Associated With Schizophrenia & Treatment With Antipsychotics

You must be logged-in to view this content.

Join Log In

Stigma & Discrimination Experienced By People Living With Severe & Persistent Mental Illness In Assertive Community Treatment Settings

You must be logged-in to view this content.

Join Log In

Dopamine Theory & Treatment Considerations In Schizophrenia

This video is part 1 in a series focusing on the psychopharmacology of schizophrenia. This video provides an overview of …

You must be logged-in to view this content.

Join Log In

Pathophysiology & Evolving Theories In Schizophrenia

This presentation is part 2 in a series focusing on the psychopharmacology of schizophrenia. This presentation reviews regions of the …

You must be logged-in to view this content.

Join Log In

Webinar Summary – Looking Beyond Mood & Psychosis: A Focus On Neurocognition

You must be logged-in to view this content.

Join Log In

Looking Beyond Mood & Psychosis: A Focus On Neurocognition

Historically, cognitive impairment was considered an artifact of patients’ symptoms, attention, or motivation problems, and as such, was an underappreciated …

You must be logged-in to view this content.

Join Log In

Are Pets A “Hidden Resource” For Self-Management Of Long-Term Mental Illness?

You must be logged-in to view this content.

Join Log In

First-Episode Psychosis Intervention Did Not Reduce Receipt Of Social Security Disability Benefits More Than Usual Care

You must be logged-in to view this content.

Join Log In

New Neuro-Pathway Affecting Schizophrenia Discovered

You must be logged-in to view this content.

Join Log In

Virtual Forum Summary: Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry

You must be logged-in to view this content.

Join Log In

Cognitive Impairment In Schizophrenia: Cognitive Remediation & The Potential Role Of Digital Technology

You must be logged-in to view this content.

Join Log In

Role Of The Caregiver In The Overall Treatment Plan

You must be logged-in to view this content.

Join Log In

Mental Health Awareness Month 2017 – Henry A. Nasrallah, MD

You must be logged-in to view this content.

Join Log In

Negative Symptoms & Functioning During The First Year After A Recent Onset Of Schizophrenia & Eight Years Later

You must be logged-in to view this content.

Join Log In

Introduction To Schizophrenia

You must be logged-in to view this content.

Join Log In

Finding Mental Health That Fits Your Cultural Background

You must be logged-in to view this content.

Join Log In

Dual Diagnosis Fact Sheet

You must be logged-in to view this content.

Join Log In

Schizophrenia Fact Sheet

You must be logged-in to view this content.

Join Log In

Sleep Disorders Fact Sheet

You must be logged-in to view this content.

Join Log In

Student Guide To Mental Health: Getting The Right Start

You must be logged-in to view this content.

Join Log In

Psychosis Fact Sheet

You must be logged-in to view this content.

Join Log In

Mental Health Facts In America

You must be logged-in to view this content.

Join Log In

Multicultural Mental Health Facts

You must be logged-in to view this content.

Join Log In

Mental Health: Know The Warning Signs

You must be logged-in to view this content.

Join Log In

Taking Charge Of Your Mental Health

You must be logged-in to view this content.

Join Log In

What Is Mental Health Parity?

You must be logged-in to view this content.

Join Log In

Mental Health: Maintaining A Healthy Lifestyle

You must be logged-in to view this content.

Join Log In

Mental Health: Managing Stress

You must be logged-in to view this content.

Join Log In

Student Guide To Mental Health: How To Help A Friend

You must be logged-in to view this content.

Join Log In

Mental Health: How To Find Help

You must be logged-in to view this content.

Join Log In

Insulin: The Overlooked Neuromodulator

You must be logged-in to view this content.

Join Log In

Stop Thinking Stupid Thoughts

You must be logged-in to view this content.

Join Log In

Think Ahead

You must be logged-in to view this content.

Join Log In

What’s Underneath

You must be logged-in to view this content.

Join Log In

Cognitive Behavioral Therapy For Psychosis Can Improve Brain Function In People With Schizophrenia

You must be logged-in to view this content.

Join Log In

Reaching For Recovery: Schizophrenia

You must be logged-in to view this content.

Join Log In

Working With The Treatment Team: Schizophrenia

You must be logged-in to view this content.

Join Log In

Connecting With Your Loved One Help Sheet: Schizophrenia

You must be logged-in to view this content.

Join Log In

Caregivers & The Right To Help: Schizophrenia

You must be logged-in to view this content.

Join Log In

Rutgers Opens Early Psychosis Intervention Clinic For Young Adults

You must be logged-in to view this content.

Join Log In

There’s A Person In There

You must be logged-in to view this content.

Join Log In

Making Yourself A Priority

You must be logged-in to view this content.

Join Log In

My Experience On How Medication & Therapy Work Together

You must be logged-in to view this content.

Join Log In

Accept Help When It’s Offered

You must be logged-in to view this content.

Join Log In

In The Workplace

You must be logged-in to view this content.

Join Log In

Mental Health Month 2016 Toolkit

You must be logged-in to view this content.

Join Log In

Webinar Summary – Impending Signs of Psychosis: Focus on Caregiver & Patient Engagement

You must be logged-in to view this content.

Join Log In

Impending Signs Of Psychosis: Focus On Caregiver & Patient Engagement

The majority of individuals who experience psychosis in schizophrenia will eventually relapse, making an individual’s ability to identify early warning …

You must be logged-in to view this content.

Join Log In

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

You must be logged-in to view this content.

Join Log In

Advanced Receptor Psychopharmacology

This video is part 3 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Join Log In

Advanced Neurotransmitters & Neuroglia

This video is part 2 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Join Log In

Follow Up Q&A – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

During this question and answer session, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP respond to unanswered questions …

You must be logged-in to view this content.

Join Log In

Webinar Summary – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Join Log In

Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

While treating to remission is the goal in schizophrenia, it remains a target not achieved for many patients. In this …

You must be logged-in to view this content.

Join Log In

Psychiatric Emergency & Crisis

You must be logged-in to view this content.

Join Log In

First-Episode Psychosis Incidence Estimated At 0.86 Per 1,000 Population Between 15-29 Years Old

You must be logged-in to view this content.

Join Log In

Characteristic Distributions Of Regional Cerebral Blood Flow Changes In Major Depressive Disorder Patients: A Pseudo-Continuous Arterial Spin Labeling (pCASL) Study

You must be logged-in to view this content.

Join Log In

Inflammation In Neurological & Psychiatric Diseases

You must be logged-in to view this content.

Join Log In

Total & Differential White Blood Cells Counts, High-Sensitivity C-Reactive Protein, & Cardiovascular Risk In Non-Affective Psychoses

You must be logged-in to view this content.

Join Log In

Auditory Dysfunction In Schizophrenia: Integrating Clinical & Basic Features

You must be logged-in to view this content.

Join Log In

The Potential Of Immune Biomarkers To Advance Personalized Medicine Approaches For Schizophrenia

You must be logged-in to view this content.

Join Log In

Pharmacokinetics: The Basics

You must be logged-in to view this content.

Join Log In

An Overview Of Treatment Options & Cost For Schizophrenia

You must be logged-in to view this content.

Join Log In

National Study Shows Rate Of Health Care Utilization Growth Slowed During 2003-2014; Adults With Serious Psychological Distress Are High Utilizers Of Services

You must be logged-in to view this content.

Join Log In

Effectively Measuring The Functional Capacity Of Individuals With Serious Mental Illness

You must be logged-in to view this content.

Join Log In

Lifestyle Interventions Get The Medicare Greenlight

You must be logged-in to view this content.

Join Log In

17% Of U.S. Adults Used Psychiatric Drugs In 2013

You must be logged-in to view this content.

Join Log In

How Does Genetic Counseling Impact Individuals With Serious Mental Illness?

You must be logged-in to view this content.

Join Log In

Detecting & Managing Cardiovascular Disease For Individuals With Serious Mental Illness

You must be logged-in to view this content.

Join Log In

Webinar Summary – Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

You must be logged-in to view this content.

Join Log In

Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

Addressing the challenges of caring for patients with schizophrenia in terms of treatment, recovery, and remission requires a coordinated effort …

You must be logged-in to view this content.

Join Log In

Half Of American Adults With Mental Health Problems Are Untreated

You must be logged-in to view this content.

Join Log In

Researchers Developing Universal Predictive Measure For Suicidality

Health care professionals understand that early intervention of serious mental illness can prevent an individual from suffering disabilities, hospitalizations, incarceration, …

You must be logged-in to view this content.

Join Log In

Measuring Personal Recovery Of People With Serious Mental Illness Using The Maryland Assessment Of Recovery Scale

You must be logged-in to view this content.

Join Log In

Ex-Offenders’ Violent Recidivism Reduced By Taking Psychotropic Medications

You must be logged-in to view this content.

Join Log In

CBT For People With Ultra-High Risk Of Psychosis Lowers Incidence By 44%

You must be logged-in to view this content.

Join Log In

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

You must be logged-in to view this content.

Join Log In

Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

While past decades saw a boom in the development of innovative new treatments in the field of psychiatry, the pace …

You must be logged-in to view this content.

Join Log In

A Comparison Of Stigmatizing Attitudes Toward Persons With Schizophrenia In Four Stakeholder Groups: Perceived Likelihood Of Violence & Desire For Social Distance

You must be logged-in to view this content.

Join Log In

A Systematic Review Of Factors Influencing Adherence To Antipsychotic Medication In Schizophrenia-Spectrum Disorders

You must be logged-in to view this content.

Join Log In

A Splitting Brain: Imbalanced Neural Networks In Schizophrenia

You must be logged-in to view this content.

Join Log In

A Molecular Pathway Analysis Informs The Genetic Background At Risk For Schizophrenia

You must be logged-in to view this content.

Join Log In

An Individualized Risk Calculator For Research In Prodromal Psychosis

You must be logged-in to view this content.

Join Log In

Unraveling The Mechanisms Responsible For The Comorbidity Between Metabolic Syndrome & Mental Health Disorders

You must be logged-in to view this content.

Join Log In

Rethinking The Genetic Basis For Comorbidity Of Schizophrenia & Type 2 Diabetes

You must be logged-in to view this content.

Join Log In

How Prevalent Are Anxiety Disorders In Schizophrenia? A Meta-Analysis & Critical Review On A Significant Association

You must be logged-in to view this content.

Join Log In

Adding CBT To Treatment Decreases Likelihood Of First Episode Psychosis In High-Risk Consumers

You must be logged-in to view this content.

Join Log In

Anxiety Comorbidity in Schizophrenia

You must be logged-in to view this content.

Join Log In

About 40% Of Inmates In San Francisco County Jail Need Behavioral Health Services; 15% Are Treated For Serious Mental Illness

You must be logged-in to view this content.

Join Log In

Payer Considerations In Managing Schizophrenia Relapse Reduction: Schizophrenia Overview

You must be logged-in to view this content.

Join Log In

Case Studies In Schizophrenia: Long-Acting Injectables (LAIs) As A Treatment Option

You must be logged-in to view this content.

Join Log In

Frameworks in Health & Quality: Schizophrenia Relapse Reduction Program

You must be logged-in to view this content.

Join Log In

A Guide For Caregivers: Understanding Schizophrenia Relapse

You must be logged-in to view this content.

Join Log In

Wellness & Recovery Workbook

This tool is designed to help patients recognize and manage symptoms of schizophrenia. Patients can use it as practical support …

You must be logged-in to view this content.

Join Log In

Preparing To Leave The Hospital

You must be logged-in to view this content.

Join Log In

A Guide For Patients: Managing Schizophrenia

You must be logged-in to view this content.

Join Log In

A Guide For Patients: Living With Schizophrenia

You must be logged-in to view this content.

Join Log In

A Guide For Patients: Understanding How Your Medicine Can Help

You must be logged-in to view this content.

Join Log In

A Guide for Patients: Understanding Schizophrenia Relapse

You must be logged-in to view this content.

Join Log In

Schizophrenia & The Role Of The Pharmacist

You must be logged-in to view this content.

Join Log In

Treatment Adherence In Schizophrenia: Engagement Strategies For Health Care Providers, Case Managers, & Advocates

You must be logged-in to view this content.

Join Log In

Case Manager: Reducing Risk Of Relapse In People With Schizophrenia

You must be logged-in to view this content.

Join Log In

Medication Reconciliation For People With Schizophrenia

You must be logged-in to view this content.

Join Log In

Medication Options For People With Schizophrenia

You must be logged-in to view this content.

Join Log In

Schizophrenia & Relapse: Key Issues & Concerns For Hospital Team Members

You must be logged-in to view this content.

Join Log In

Schizophrenia & Relapse: Key Issues & Concerns For Health Care Providers

You must be logged-in to view this content.

Join Log In

Case Study In Schizophrenia: Long-Acting Injectables As A Treatment Option—Jenny

You must be logged-in to view this content.

Join Log In

Case Study In Schizophrenia: Long-Acting Injectables As A Treatment Option—Anton

You must be logged-in to view this content.

Join Log In

Addressing Relapse & Readmissions In Schizophrenia

You must be logged-in to view this content.

Join Log In

HEDIS Quality Improvement Project: Measurement & Intervention Development

This document outlines potential opportunities for health care quality improvement that may be derived from HEDIS®. Two particular HEDIS® measures …

You must be logged-in to view this content.

Join Log In

Schizophrenia & Relapse: Key Issues & Concerns For Payers

You must be logged-in to view this content.

Join Log In

Cómo Prepararse Para Dejar El Hospital – Versión Española

You must be logged-in to view this content.

Join Log In

Guía Para Pacientes: Cómo Controlar La Esquizofrenia – Versión Española

You must be logged-in to view this content.

Join Log In

Guía Para Pacientes: Vivir Con Esquizofrenia – Versión Española

You must be logged-in to view this content.

Join Log In

Cuaderno De Trabajo Sobre El Bienestar Y La Recuperación – Versión Española

You must be logged-in to view this content.

Join Log In

Guía Para Cuidadores: Comprender Qué Es Una Recaída En La Esquizofrenia- Versión Española

You must be logged-in to view this content.

Join Log In

Guía Para Pacientes: Comprender Cómo Los Medicamentos Pueden Ayudar – Versión Española

You must be logged-in to view this content.

Join Log In

Guía Para Pacientes: Comprender Qué Es Una Recaída En La Esquizofrenia – Versión Española

You must be logged-in to view this content.

Join Log In

Phenotypically Distinct Subtypes of Psychosis Accompany Novel or Rare Variants in Four Different Signaling Genes

You must be logged-in to view this content.

Join Log In

Brain Scans Of Individuals With Schizophrenia Show Regeneration Of Damaged Brain Matter Over Time

You must be logged-in to view this content.

Join Log In

Risk Factors Associated With Psychiatric Readmission

You must be logged-in to view this content.

Join Log In

Children Living In Urban Areas Have Higher Rates Of Psychotic Symptoms

You must be logged-in to view this content.

Join Log In

New Maine Medicaid Policy Limits Most Mental Health Community Support Services To People With Schizophrenia Or Schizoaffective Disorder

You must be logged-in to view this content.

Join Log In

Follow Up Q&A – Managing Metabolic Wellness In The Mentally Ill: Perspectives From Both A Primary Care Provider (PCP) & A Psychiatrist

You must be logged-in to view this content.

Join Log In

Webinar Summary – Managing Metabolic Wellness In The Mentally Ill: Perspectives From A Primary Care Physician & A Psychiatrist

You must be logged-in to view this content.

Join Log In

Managing Metabolic Wellness In The Mentally Ill: Perspectives From Both A Primary Care Physician (PCP) & A Psychiatrist

Metabolic wellness is an extremely important consideration in treating patients with schizophrenia, who have an increased incidence of cardiometabolic risk …

You must be logged-in to view this content.

Join Log In

People Diagnosed With Schizophrenia Use Digital Technology At Same Rate As General Population

You must be logged-in to view this content.

Join Log In

Readmission Patterns & Effectiveness of Transitional Care Among Medicaid Patients With Schizophrenia & Medical Comorbidity

You must be logged-in to view this content.

Join Log In

Four New Genetic Diseases Defined Within Schizophrenia

You must be logged-in to view this content.

Join Log In

What Are Residual Symptoms in Schizophrenia Spectrum Disorder? Clinical Description & 1-Year Persistence Within a Naturalistic Trial

You must be logged-in to view this content.

Join Log In

Webinar Summary – Understanding & Addressing Medication Adherence In Psychiatry

You must be logged-in to view this content.

Join Log In

Interview with Lurline Nieto | Psychiatric Nurse Practitioner

You must be logged-in to view this content.

Join Log In

Metabolic Syndrome In Bipolar Disorder & Schizophrenia: Dietary & Lifestyle Factors Compared To The General Population

You must be logged-in to view this content.

Join Log In

Defining Therapeutic Benefit For People With Schizophrenia: Focus On Negative Symptoms

You must be logged-in to view this content.

Join Log In

First Outpatient Follow-up After Psychiatric Hospitalization: Does One Size Fit All?

You must be logged-in to view this content.

Join Log In

Schizophrenia—A Medical Psychiatric Syndrome

You must be logged-in to view this content.

Join Log In

Webinar Summary – Recovery In The Community: Can We Do Better?

You must be logged-in to view this content.

Join Log In

Recovery In The Community: Can We Do Better?

A goal for all patients with mental illness should be symptom reduction and optimal psychosocial functioning. In this webinar, experienced …

You must be logged-in to view this content.

Join Log In

A Longitudinal Examination Of The Moderating Effects Of Symptoms On The Relationship Between Functional Competence & Real World Functional Performance In Schizophrenia

You must be logged-in to view this content.

Join Log In

Co-Occurring Psychotic & Addictive Disorders: Neurobiology & Diagnosis

You must be logged-in to view this content.

Join Log In

Approaches To Improve Adherence To Pharmacotherapy In Patients With Schizophrenia

You must be logged-in to view this content.

Join Log In

You must be logged-in to view this content.

Join Log In

Webinar Summary – Suboptimal Response in Psychotic & Mood Disorders: Causes, Consequences, & Management Strategies

You must be logged-in to view this content.

Join Log In

Suboptimal Response In Psychotic & Mood Disorders: Causes, Consequences, & Management Strategies

Suboptimal response is a common challenge and can lead to negative consequences for patients diagnosed with serious mental illness. In …

You must be logged-in to view this content.

Join Log In

An Updated Review On Burden On Caregivers Of Schizophrenia Patients

You must be logged-in to view this content.

Join Log In

Psychiatric Readmissions In A Community-Based Sample Of Patients With Mental Disorders

You must be logged-in to view this content.

Join Log In

56% Of Medicaid Beneficiaries With A Psychiatric Diagnosis Had Claims For Psychotropic Medications

You must be logged-in to view this content.

Join Log In

Psychiatric 30-Day Readmission Rates Were 9% For Mood Disorders; 15% For Schizophrenia

You must be logged-in to view this content.

Join Log In

Webinar Summary – A Foundational Approach To The Treatment Of Schizophrenia

You must be logged-in to view this content.

Join Log In

A Foundational Approach To The Treatment Of Schizophrenia

Schizophrenia is a chronic and devastating illness, affecting more than 21 million people globally. In this webinar, experienced psychiatrists Noel …

You must be logged-in to view this content.

Join Log In

Perspectives In Schizophrenia: Proposed Disease Pathophysiology & Potential Treatment Implications

You must be logged-in to view this content.

Join Log In

‘Antipsychotics Are Alike, But Their Similarities Are Different’

You must be logged-in to view this content.

Join Log In

Use Of Biotypes Offers More Precise Diagnoses Of SMI Than The DSM

You must be logged-in to view this content.

Join Log In

Webinar Summary – A Collaborative Approach To Care Coordination For Patients With Schizophrenia: Perspectives From Nursing & Social Work

You must be logged-in to view this content.

Join Log In

A Collaborative Approach To Care Coordination For Patients With Schizophrenia: Perspectives From Nursing & Social Work

Many patients with schizophrenia fail to transition from inpatient settings to community mental health settings. In this webinar, Brooke Kempf …

You must be logged-in to view this content.

Join Log In

Detection & Characteristics Of Individuals With A Very Long Duration Of Untreated Psychosis In An Early Intervention For Psychosis Service

You must be logged-in to view this content.

Join Log In

Clinical Correlates Of Initial Treatment Disengagement In First-Episode Psychosis

You must be logged-in to view this content.

Join Log In

Who Is Paying The Price? Loss Of Health Insurance Coverage Early In Psychosis

You must be logged-in to view this content.

Join Log In

Is Early Intervention For Psychosis Feasible & Effective?

You must be logged-in to view this content.

Join Log In

Inflammation & The Two-Hit Hypothesis Of Schizophrenia

You must be logged-in to view this content.

Join Log In

The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies

You must be logged-in to view this content.

Join Log In

Comprehensive Versus Usual Community Care For First-Episode Psychosis: 2-Year Outcomes From The NIMH RAISE Early Treatment Program

You must be logged-in to view this content.

Join Log In

Pathways To (Specialized) Care: Patient Costs & Contacts En Route To A First-Episode Psychosis Clinic

You must be logged-in to view this content.

Join Log In

The Challenges Of Treating Patients With Schizophrenia

You must be logged-in to view this content.

Join Log In

Severity Of Psychosis Syndrome & Change Of Metabolic Abnormality In Chronic Schizophrenia Patients: Severe Negative Syndrome May Be Related To A Distinct Lipid Pathophysiology

You must be logged-in to view this content.

Join Log In

Early Intervention In Psychosis

You must be logged-in to view this content.

Join Log In

Mortality Rates Among Adult Medicaid Beneficiaries With Schizophrenia 3.5 Times Higher Than General Population

You must be logged-in to view this content.

Join Log In

Smartphone App Found Feasible For Managing Schizophrenia

You must be logged-in to view this content.

Join Log In

Comprehensive, Team-Based Treatment For First Episode Psychosis Linked To Better Outcomes Than Traditional Community-Based Treatment

You must be logged-in to view this content.

Join Log In

Do People With Serious Mental Illness Receive Quality Medical Care?

You must be logged-in to view this content.

Join Log In

Violent Reoffenses More Likely In Ex-Offenders With Psychiatric Diagnoses

You must be logged-in to view this content.

Join Log In

Men With Schizophrenia Make Twice As Many Emergency Department Visits As Women With Schizophrenia

You must be logged-in to view this content.

Join Log In

Individuals With Serious Mental Illness (SMI) & Type 2 Diabetes: Clinical Correlates Of Diabetes Control

You must be logged-in to view this content.

Join Log In

Investigating White Matter Abnormalities In Brains Of People With Schizophrenia

You must be logged-in to view this content.

Join Log In

Rearrest Rates Drop From 80% To 28% For Mental Health Court Participants

You must be logged-in to view this content.

Join Log In

Brief Adherence Ratings Scale (BARS)

You must be logged-in to view this content.

Join Log In

Early Intervention In Psychosis: Benefits, Barriers, & Best Practices

You must be logged-in to view this content.

Join Log In

Older Adults Prescribed Psychotropics At Twice The Rate Of Younger Adults, But See Psychiatrists Less

You must be logged-in to view this content.

Join Log In

The Neurobiology Of Relapse In Schizophrenia

You must be logged-in to view this content.

Join Log In

Developing A Cognitive Training Strategy For First-Episode Schizophrenia: Integrating Bottom-Up & Top-Down Approaches

You must be logged-in to view this content.

Join Log In

Dopamine Supersensitivity Psychosis (DSP): Is It A Factor in Treatment-Resistant Schizophrenia?

You must be logged-in to view this content.

Join Log In

Co-Morbidity Of Alcohol Use Disorders & Schizophrenia In The Developing World

You must be logged-in to view this content.

Join Log In

The Role Of Pro-Inflammatory Cytokines In The Neuroinflammation & Neurogenesis Of Schizophrenia

You must be logged-in to view this content.

Join Log In

Half Medicaid Population With SMI Do Not Receive Continuous Supply Of Psych Meds

You must be logged-in to view this content.

Join Log In

Best Practice: Clinical Practice Guideline: Optum Schizophrenia Coverage Determination Guidelines

You must be logged-in to view this content.

Join Log In

The Current State Of Schizophrenia From Rebecca Roma, MD, MBA

You must be logged-in to view this content.

Join Log In

The Current State Of Schizophrenia From Peter J. Weiden, MD

You must be logged-in to view this content.

Join Log In

Webinar Summary – Distinguishing Sedation From Efficacy In Antipsychotic Treatment

You must be logged-in to view this content.

Join Log In

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Agitation is frequently seen in patients with schizophrenia. When treating acute agitation in these patients, minimizing sedation should be a …

You must be logged-in to view this content.

Join Log In

Managing The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

You must be logged-in to view this content.

Join Log In

Early Intervention For Psychotic Disorders In A Community Mental Health Center

You must be logged-in to view this content.

Join Log In

Reducing Duration Of Untreated Psychosis: Care Pathways To Early Intervention In Psychosis Services

You must be logged-in to view this content.

Join Log In

An Overview Of The Brief Adherence Rating Scale (BARS)

You must be logged-in to view this content.

Join Log In

An Innovative Method Of Teaching Psychopharmacology To Psychiatry Residents

You must be logged-in to view this content.

Join Log In

Long-Term Follow-Up Of The TIPS Early Detection In Psychosis Study: Effects On 10-Year Outcome

You must be logged-in to view this content.

Join Log In

Webinar Summary – Treating The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

You must be logged-in to view this content.

Join Log In

Treating The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

Psychosis is ranked as one of the top three most disabling conditions worldwide. Quality of life is commonly impaired in …

You must be logged-in to view this content.

Join Log In

Disengagement From Mental Health Treatment Among Individuals With Schizophrenia & Strategies For Facilitating Connections To Care: A Review Of The Literature

You must be logged-in to view this content.

Join Log In

Impact Of Early Intervention Services On Duration Of Untreated Psychosis: Data From The National EDEN Prospective Cohort Study

You must be logged-in to view this content.

Join Log In

People With Mental Health Issues Have Higher Than Average Mortality Rate, With 14.3% Of Deaths Worldwide Attributable To Mental Health Disorders

You must be logged-in to view this content.

Join Log In

New Neuroimaging Research May Change The Way Mental Illness Is Diagnosed

You must be logged-in to view this content.

Join Log In

Youth With Certain Genetic Disorders Are Likely To Show Cognitive Decline Before Onset Of Psychosis

You must be logged-in to view this content.

Join Log In

UK Releases New Quality Of Care Standards For Adults Diagnosed With Psychosis Or Schizophrenia

You must be logged-in to view this content.

Join Log In

Global Burden Of Disease Attributable To Mental & Substance Use Disorders: Findings From The Global Burden Of Disease Study 2010

You must be logged-in to view this content.

Join Log In

Reduction In Incidence Of Hospitalizations For Psychotic Episodes Through Early Identification & Intervention

You must be logged-in to view this content.

Join Log In

Reducing The Duration Of Untreated Psychosis & Its Impact In The U.S.: The STEP-ED Study

You must be logged-in to view this content.

Join Log In

‘Intelligent Assignment’ To Medicare Part D Plans Of Beneficiaries With Schizophrenia Could Save $150 Million Annually

You must be logged-in to view this content.

Join Log In

OmniComm Systems’ TrialMaster Selected By European Group For Research In Schizophrenia

You must be logged-in to view this content.

Join Log In

The Brief Adherence Rating Scale (BARS) Validated Against Electronic Monitoring In Assessing The Antipsychotic Medication Adherence Of Outpatients With Schizophrenia & Schizoaffective Disorder

You must be logged-in to view this content.

Join Log In

Towards A Pragmatic & Operational Definition Of Relapse In Schizophrenia: A Delphi Consensus Approach

You must be logged-in to view this content.

Join Log In

Addressing The Transition Of Care For Patients With Schizophrenia: A Case Study Approach

You must be logged-in to view this content.

Join Log In

Webinar Summary – Early Intervention In Psychosis: Benefits, Barriers, & Best Practices

You must be logged-in to view this content.

Join Log In

Early Intervention In Psychosis: Benefits, Barriers & Best Practices

Psychosis is ranked as one of the top three most disabling conditions worldwide, with a longer duration of untreated psychosis …

You must be logged-in to view this content.

Join Log In

“Sometimes It’s Difficult To Have A Normal Life”: Results From A Qualitative Study Exploring Caregiver Burden In Schizophrenia

You must be logged-in to view this content.

Join Log In

Exploratory Analysis Of Social Cognition & Neurocognition In Individuals At Clinical High Risk For Psychosis

You must be logged-in to view this content.

Join Log In

Webinar Summary – Facilitating Recovery In Schizophrenia: An Assertive Community Treatment Approach

You must be logged-in to view this content.

Join Log In

Facilitating Recovery In Schizophrenia: An Assertive Community Treatment Approach

Why is the concept of recovery important to patients with schizophrenia? What are some barriers to recovery? How can an …

You must be logged-in to view this content.

Join Log In

Effectiveness Of Continuity-Of-Care Programs To Reduce Time In Hospital In Persons With Schizophrenia

You must be logged-in to view this content.

Join Log In

Social Cognition As A Mediator Between Neurocognition & Functional Outcome In Individuals At Clinical High Risk For Psychosis

You must be logged-in to view this content.

Join Log In

Schizophrenia Genetics: Emerging Themes For A Complex Disorder

You must be logged-in to view this content.

Join Log In

Metabolic Wellness Considerations In Schizophrenia

You must be logged-in to view this content.

Join Log In

Webinar Summary – Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

You must be logged-in to view this content.

Join Log In

Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

There is a continuous debate in the mental health community around the progressive nature of schizophrenia as a disease: Is …

You must be logged-in to view this content.

Join Log In

Different & Shared Brain Volume Abnormalities In Late- & Early-Onset Schizophrenia

You must be logged-in to view this content.

Join Log In

Assertive Community Treatment: Bridging The Gaps In The Community

You must be logged-in to view this content.

Join Log In

Psychometric Properties Of The Questionnaire About The Process Of Recovery (QPR)

You must be logged-in to view this content.

Join Log In

Is Personal Recovery In Schizophrenia Predicted By Low Cognitive Insight?

You must be logged-in to view this content.

Join Log In

Fear Of Recurrence: Results Of A Randomized Trial Of Relapse Detection In Schizophrenia

You must be logged-in to view this content.

Join Log In

Design & Validation Of Standardized Clinical & Functional Remission Criteria In Schizophrenia

You must be logged-in to view this content.

Join Log In

The Nature Of Relapse In Schizophrenia

You must be logged-in to view this content.

Join Log In

Predicting Engagement With Services For Psychosis: Insight, Symptoms & Recovery Style

You must be logged-in to view this content.

Join Log In

Are There Clinically Useful Predictors & Early Warning Signs For Pending Relapse?

You must be logged-in to view this content.

Join Log In

Validating A Brief Version Of The Mental Health Recovery Measure For Individuals With Schizophrenia

You must be logged-in to view this content.

Join Log In

Why Are The Outcomes In Patients With Schizophrenia So Poor?

You must be logged-in to view this content.

Join Log In

The Onset & Offset Of Psychosis – & What Happens In Between

You must be logged-in to view this content.

Join Log In

Recovery In Psychosis: A Delphi Study With Experts By Experience

You must be logged-in to view this content.

Join Log In

Assessing Early Signs Of Relapse In Psychosis: Review & Future Directions

You must be logged-in to view this content.

Join Log In

Using Longitudinal Imaging To Map The ‘Relapse Signature’ Of Schizophrenia & Other Psychoses

You must be logged-in to view this content.

Join Log In

The Importance Of Adherence To Long-Term Success In Schizophrenia

You must be logged-in to view this content.

Join Log In

Systemwide Adoption Of Behavioral Health & Primary Care Integration Estimated To Save $26 Billion Annually

You must be logged-in to view this content.

Join Log In

Measurements Of Response, Remission & Recovery In Schizophrenia & Examples For Their Clinical Application

Now Leaving PsychU

This link will take you outside of the PsychU community website